US approves second gene therapy against cancer


US regulators have approved a second form of gene therapy to fight cancer. The treatment, called Yescarta, is the first immunotherapy on the US market for certain kinds of non-Hodgkin lymphoma (NHL), a cancer that attacks the lymph nodes. Known as a chimeric antigen receptor (CAR) T cell therapy, Yescarta modifies a patient’s white blood cells…




US approves second gene therapy against cancer
US approves second gene therapy against cancer

Comments

Loading Facebook Comments ...
Loading Disqus Comments ...